Rezultati pretraživanja
  1. Merck & Co. Inc. Downgraded To 'AA-', Ratings On CreditWatch Negative On Rising Debt Leverage And Planned Spin-Off

  2. prije 5 sati
    Odgovor korisniku/ci

    check out my latest post on spin out of hodge-podge product lines including licensed from Samsung Bioepis. Would make sense for to do another spinout of then do a M&E with with better marketing org. Eliminate duplicate R&D.

  3. prije 6 sati

    Traded and . My goal is to post my trades every day, win or lose.

    Prikaži ovu nit
  4. prije 11 sati

    February 4, 2020 Reporting after the close February 5, 2020 Reporting before the open

    Prikaži ovu nit
  5. prije 11 sati

    Join at 8 a.m. ET to learn more about our 4Q and fullyear 2019 earnings httpmerck.us2J2xAUhÂpic.twitter.comBqchaiWAuy: Join at 8 a.m. ET to learn more about our 4Q and fullyear 2019 earnings httpmerck.us2J2xAUh pic.twitter.comBqchaiWAuy

  6. prije 11 sati

    A lot of great opportunities today. Ended up trading and . A scalp trade on , but definitely could have held on to it for longer given the strong support on its daily chart.

  7. prije 13 sati

    Investingcom: RT : 🚨 Wednesday's Most Anticipated Releases (via ) 🚨 Before The Bell: After The Bell:

  8. prije 15 sati

    Merck & Co. Q419 Earnings: -Revenue: $11.9B (est $11.98B) -Adj EPS: $1.16 (est $1.15) -Keytruda Revenue: $3.11B (est $3.30B) -Sees 2020 Sales : $48.80B To $50.3B (est $49.43B) -Sees 2020 Adj EPS: $5.62 To $5.77 (est $5.67)

  9. prije 15 sati

    90 new products 🇺🇸🇺🇸🇺🇸🇺🇸🐐🤑

  10. 4. velj
  11. 4. velj

    OPTIONS TRADE Bought 7FEB20 92C at .29 for an earnings. I have no idea which way it'll go (like with all earnings) but hoping upwards!

    Prikaži ovu nit
  12. 3. velj

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.